Previous Close | 957.00 |
Open | 958.00 |
Bid | 876.60 x 200 |
Ask | 955.11 x 100 |
Day's Range | 950.27 - 962.10 |
52 Week Range | 684.81 - 998.33 |
Volume | |
Avg. Volume | 469,198 |
Market Cap | 105.039B |
Beta (5Y Monthly) | 0.14 |
PE Ratio (TTM) | 28.14 |
EPS (TTM) | 33.88 |
Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1,052.64 |
In this article, we discuss the 23 most profitable stocks of the last 12 months. If you want to skip our detailed analysis of these stocks, go directly to 5 Most Profitable Stocks of the Last 12 Months. The United States stock market has come a long way since the turn of the millennium more […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
Regeneron Pharmaceuticals ( NASDAQ:REGN ) First Quarter 2024 Results Key Financial Results Revenue: US$3.15b (flat on...